temozolomide,capecitabine
Not Tagged
['rectal', 'prodige 23']
 total neoadjuvant therapy with mfolfirinox versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of prodige 23 phase iii trial #asco2023 461 pts, follow-up 82 mo dfs &amp; mfs maintained tnt improves overall os 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology